Experimental autoimmune encephalomyelitis accelerates remyelination after lysophosphatidylcholine-induced demyelination in the corpus callosum

Anna Claire Lamport, Matthew Chedrawe, Matthew Nichols, George S. Robertson

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

3 Citas (Scopus)

Resumen

Experimental autoimmune encephalomyelitis (EAE) and lysophosphatidylcholine (LPC)-induced demyelination were combined to study remyelination in a pro-inflammatory context. Two groups of female C57BL/6 mice were subjected either to EAE (EAE mice) or injected with just complete Freund's adjuvant (CFA) and pertussis toxin (PTX) followed by bilateral LPC and phosphate buffered saline injections in the corpus callosum on day 7 (CFA controls). Relative to CFA controls, EAE accelerated remyelination and increased innate immune cell activation, lymphocyte infiltration and cytokine gene expression in the LPC lesions. However, compared to CFA mice, remyelination was reduced (day 14) suggesting this aggressive immune response also compromised myelin repair in EAE mice.

Idioma originalEnglish
Número de artículo576995
PublicaciónJournal of Neuroimmunology
Volumen334
DOI
EstadoPublished - sep. 15 2019

Nota bibliográfica

Funding Information:
This work was supported by funding from the MS Society of Canada ( EGID 2983 ).

Publisher Copyright:
© 2019 Elsevier B.V.

ASJC Scopus Subject Areas

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology

Huella

Profundice en los temas de investigación de 'Experimental autoimmune encephalomyelitis accelerates remyelination after lysophosphatidylcholine-induced demyelination in the corpus callosum'. En conjunto forman una huella única.

Citar esto